The FDA subsequently allowed imports of the cancer drug from China, from Qilu Pharmaceutical, whose version of the drug is unapproved in the U.S. Georgia’s elected officials are asking the FDA ...
An Israeli company that has a U.S. headquarters in Waltham said Monday it has received approval for a new drug for blood cancer. Biopharmaceutical company BioLineRx Ltd. (Nasdaq: BLRX) said the U ...
The US Food and Drug Administration (FDA) has increased its collaboration with cancer drug manufacturers in a bid to overcome the country’s ongoing drug shortage problem and reduce impacts on patients ...
A cancer diagnosis is already devastating. It’s even more gut-wrenching when your doctor tells you that a drug shortage has disrupted your treatment regimen—that your hospital can’t get its ...
What do you do when the country you rely on for your life-saving medicines is the one you consider your systemic rival? Every day, many tons of chemicals are churned out in Chinese factories, which ...
An Israeli company that has a U.S. headquarters in Waltham said Monday it has received approval for a new drug for blood cancer. Biopharmaceutical company BioLineRx Ltd. said the U.S. Food and ...
GSK (NYSE:GSK) has received FDA approval for its drug Ojjaara, also known as momelotinib, for the treatment of the blood cancer myelofibrosis in patients with anemia. The drug is a once daily ...
The Food and Drug Administration granted Merck a priority review for its application for Keytruda in combination with concurrent chemoradiotherapy, the company announced Wednesday. According to Merck, ...
The U.S. Food and Drug Administration (FDA) has approved the first drug in a family of medicines known as JAK inhibitors that can treat myelofibrosis patients with anemia. Momelotinib (Ojjaara) is ...
A group of advisers to the Food and Drug Administration voted in favor of Alnylam Pharmaceuticals’ treatment for a debilitating heart disease Wednesday, but only after a day-long debate ...
BioLineRx, an Israeli biotech that set up US operations in Waltham last year, said Monday that it has won federal approval to sell a new drug that helps doctors collect stem cells to treat ...
(MENAFN- PR Newswire) SINGAPORE, Sept. 11, 2023 /PRNewswire/ -- On September 9th, 2023, Biosyngen Pte Ltd (hereafter as "Biosyngen") announced that the U.S. FDA has cleared the Investigational New ...
